IMMUNITRACK ApS: Financial statements 2017
CVR: 32347908
Source: annual report 2017, Danish Business Authority
01/06/2016 – 31/05/2017
IMMUNITRACK ApS (CVR 32347908) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 1,016,932 and a net result of DKK 238,536 compared with DKK 22,671 the year before. That is an increase of 110.7% compared with the year before. Equity in the 2017 report amounted to DKK 287,938. The solvency ratio was 25.9%.
- Gross Profit
- DKK 1,016,932
- Profit/Loss
- DKK 238,536
- Equity
- DKK 287,938
- Total Assets
- DKK 1,113,298
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 1 mio. | 239 t. | 288 t. | - |
| 2016 | - | 483 t. | 23 t. | 49 t. | - |
Keep an eye on IMMUNITRACK ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of August 31, 2017, Stephan Pascal Thorgrimsen has joined the board of directors of IMMUNITRACK ApS.
As of August 31, 2017, Sune Frankild has joined the board of directors of IMMUNITRACK ApS.
As of August 31, 2017, Sune Frederik Lamdahl Justesen is registered as chairman of IMMUNITRACK ApS.
As of August 31, 2017, Sune Frederik Lamdahl Justesen has stepped down as director of IMMUNITRACK ApS.
About IMMUNITRACK ApS
IMMUNITRACK ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2013. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 6 employees (2018). In 2024, the company reported a gross profit of DKK 141,975,865 and a net result of DKK 110,009,470 compared with DKK -194,097 the year before. Equity in the 2024 report amounted to DKK 21,211,816.